Literature DB >> 28233357

Promotion of invasion by mutant RAS is dependent on activation of the WASF3 metastasis promoter gene.

Yong Teng1, Lambert Ngoka1, John K Cowell1.   

Abstract

Metastasis represents an end stage in the evolution of cancer progression and has been related to specific genetic pathways. Overexpression of mutant RAS in particular appears to promote invasion and metastasis, although exactly how this occurs has not been well characterized. It was previously showed that activation of the WASF3 protein regulates actin cytoskeleton dynamics that promote invasion. In this report, how WASF3 overexpression interacts with mutant RAS to increase invasion and metastasis was investigated. The ability of RAS to promote invasion and metastasis was shown to be dependent on WASF3 activation in a PI3K and AKT dependent manner. Proteomics analysis demonstrates the presence of AKT in the WASF3 immunocomplex which is enhanced by overexpression of mutant RAS. During these processes activation of ERK1/2 is not affected by loss of WASF3 expression. Analysis of the relative involvement of p85 and p110 in the WASF3 complex demonstrates that mutant RAS promotes dissociation of p85 promoting activation of p110. These studies provide a deeper understanding of the critical role for WASF3 in facilitating increased invasion potential in cancer cells expressing mutant RAS and supports the idea that targeting WASF3 in metastatic cells overexpressing RAS may be used to suppress invasion and metastasis.
© 2017 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28233357      PMCID: PMC5609680          DOI: 10.1002/gcc.22453

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  31 in total

1.  WAVE3-mediated cell migration and lamellipodia formation are regulated downstream of phosphatidylinositol 3-kinase.

Authors:  Khalid Sossey-Alaoui; Xiurong Li; Tamara A Ranalli; John K Cowell
Journal:  J Biol Chem       Date:  2005-04-11       Impact factor: 5.157

Review 2.  Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer.

Authors:  Helena Linardou; Issa J Dahabreh; Dimitra Kanaloupiti; Fotios Siannis; Dimitrios Bafaloukos; Paris Kosmidis; Christos A Papadimitriou; Samuel Murray
Journal:  Lancet Oncol       Date:  2008-09-17       Impact factor: 41.316

3.  Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases.

Authors:  Y Teng; M Q Ren; R Cheney; S Sharma; J K Cowell
Journal:  Br J Cancer       Date:  2010-08-17       Impact factor: 7.640

Review 4.  The role of wild type RAS isoforms in cancer.

Authors:  Bingying Zhou; Channing J Der; Adrienne D Cox
Journal:  Semin Cell Dev Biol       Date:  2016-07-13       Impact factor: 7.727

Review 5.  Genetic determinants of cancer metastasis.

Authors:  Don X Nguyen; Joan Massagué
Journal:  Nat Rev Genet       Date:  2007-05       Impact factor: 53.242

6.  Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cells.

Authors:  Khalid Sossey-Alaoui; Alfiya Safina; Xiurong Li; Mary M Vaughan; David G Hicks; Andrei V Bakin; John K Cowell
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

7.  Ha-Ras transformation of MCF10A cells leads to repression of Singleminded-2s through NOTCH and C/EBPbeta.

Authors:  T L Gustafson; E Wellberg; B Laffin; L Schilling; R P Metz; C A Zahnow; W W Porter
Journal:  Oncogene       Date:  2009-01-26       Impact factor: 9.867

8.  Mitochondrial ATAD3A combines with GRP78 to regulate the WASF3 metastasis-promoting protein.

Authors:  Y Teng; X Ren; H Li; A Shull; J Kim; J K Cowell
Journal:  Oncogene       Date:  2015-03-30       Impact factor: 9.867

Review 9.  WASP and WAVE family proteins: key molecules for rapid rearrangement of cortical actin filaments and cell movement.

Authors:  T Takenawa; H Miki
Journal:  J Cell Sci       Date:  2001-05       Impact factor: 5.285

10.  WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cells.

Authors:  Y Teng; Y Mei; L Hawthorn; J K Cowell
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

View more
  3 in total

1.  ABI1-based expression signature predicts breast cancer metastasis and survival.

Authors:  Angelina Regua; Csaba Papp; Andre Grageda; Baylee A Porter; Tiffany Caza; Isabelle Bichindaritz; Mira Krendel; Abirami Sivapiragasam; Gennady Bratslavsky; Vladimir A Kuznetsov; Leszek Kotula
Journal:  Mol Oncol       Date:  2022-01-26       Impact factor: 7.449

2.  Circumventing AKT-Associated Radioresistance in Oral Cancer by Novel Nanoparticle-Encapsulated Capivasertib.

Authors:  Liwei Lang; Tiffany Lam; Alex Chen; Caleb Jensen; Leslie Duncan; Feng-Chong Kong; Zoya B Kurago; Chloe Shay; Yong Teng
Journal:  Cells       Date:  2020-02-25       Impact factor: 6.600

Review 3.  Targeting WASF3 Signaling in Metastatic Cancer.

Authors:  Reid Loveless; Yong Teng
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.